Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · IEX Real-Time Price · USD
1.820
+0.050 (2.82%)
Jul 22, 2024, 9:49 AM EDT - Market open
Alterity Therapeutics Employees
Alterity Therapeutics had 11 employees as of June 30, 2023. The number of employees decreased by 1 or -8.33% compared to the previous year.
Employees
11
Change (1Y)
-1
Growth (1Y)
-8.33%
Revenue / Employee
n/a
Profits / Employee
-$759,540
Market Cap
17.95M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Singular Genomics Systems | 255 |
BiomX | 71 |
MEI Pharma | 46 |
Kala Pharmaceuticals | 43 |
Vincerx Pharma | 42 |
American Shared Hospital Services | 31 |
Oncternal Therapeutics | 30 |
NeurAxis | 19 |
ATHE News
- 5 days ago - Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy - GlobeNewsWire
- 5 days ago - Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy - GlobeNewsWire
- 5 weeks ago - Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences' Webinar - GlobeNewsWire
- 7 weeks ago - Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study - GlobeNewsWire
- 2 months ago - Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review - GlobeNewsWire
- 2 months ago - Appendix 4C – Q3 FY24 Quarterly Cash Flow Report - GlobeNewsWire
- 3 months ago - Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich's Ataxia - GlobeNewsWire
- 3 months ago - Alterity Therapeutics Parkinson's Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting - GlobeNewsWire